Giorgio Carere
Ethica Group
Pharcoterm
Deal Type
Company sale
Sector
Consumer
Completion Date
22nd June 2018
Deal Value
Not disclosed
Company Background
Pharcoterm is an Italian company active in contract manufacturing and packaging of food supplements and medical devices for the pharmaceutical industry.
Founded in 1985, Pharcoterm is a recognized strategic supplier to well-known pharma companies, that offers a product portfolio of more than 200 SKUs manufactured and packaged in solid dosage forms (powders, capsules and tablets).
In 2017, Pharcoterm achieved a total turnover of approximately €13 mln, with ca. 16% EBITDA margin.
Deal Summary
Ethica Corporate Finance advised the shareholder of Pharcoterm in the sale to Nutrilinea, an Italian CMO backed by private equity fund Whitebridge Investments.
Value Added
Leveraging on the deep understanding of the food supplements market, Ethica involved a selected group of financial and industrial buyers in the auction, granting the highest net equity proceeds to the shareholders
Pharcoterm deal contacts
Key members of the Ethica Group deal team crucial in the Pharcoterm transaction
Latest Mergers Alliance News
Mergers Alliance celebrated its Spring 2025 Conference in Barcelona (Spain) hosted by Spanish partners, NORGESTION
Proventis Partners (Germany) advised International School Potsdam and International School Erfurt on their sale to AcadeMedia
Opus Corporate Finance (UK) advises Swiss Life Asset Managers on its partnership with Planet Farms
Dresner Partner, (USA) advised Therafin Corporation on its partnership with Altimatemedical
Khronos Advisory (Thailand) has advised Electricity Generating Public Company Limited (EGCO) on USD95 million capital increase in PT Chandra Daya Investasi
Dresner Partners (USA) advised Connoisseurs Products on its sale to Willert Home Products
Ethica Group (Italy) advised Vicenza Mode, high-end knitwear manufacturer, in the sale of a majority stake to Sienna PE
